{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:51:42Z","timestamp":1789177902201,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-EU-131-5720"],"award-info":[{"award-number":["IN-EU-131-5720"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Invasive aspergillosis (IA) is a major cause of mortality in immunocompromised patients and it is difficult to diagnose because of the lack of reliable highly sensitive diagnostics. We aimed to identify circulating immunological markers that could be useful for an early diagnosis of IA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected longitudinally serum samples from 33 cases with probable\/proven IA and two matched control cohorts without IA (one with microbiological and clinical evidence of bacterial or viral non-fungal pneumonia and one without evidence of infection, all matched for neutropenia, primary underlying disease, and receipt of corticosteroids\/other immunosuppressants) at a tertiary university hospital. In addition, samples from an independent cohort (n\u2009=\u200920 cases of proven\/probable IA and 20 matched controls without infection) were obtained. A panel of 92 circulating proteins involved in inflammation was measured by proximity extension assay. A random forest model was used to predict the development of IA using biomarkers measured before diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While no significant differences were observed between IA cases and infected controls, concentrations of 30 inflammatory biomarkers were different between cases and non-infected controls, of which nine were independently replicated: PD-L1, MMP-10, Interleukin(IL)-10, IL-15RA, IL-18, IL-18R1, CDCP1, CCL19 and IL-17C. From the differential abundance analysis of serum samples collected more than 10\u00a0days before diagnosis and at diagnosis, increased IL-17C concentrations in IA patients were replicated in the independent cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An increased circulating concentration of IL-17C was detected both in the discovery and independent cohort, both at the time of diagnosis and in samples 10\u00a0days before the diagnosis of IA, suggesting it should be evaluated further as potential (early) biomarker of infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11046-024-00831-8","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T06:02:32Z","timestamp":1708927352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies\u2014an Exploratory Study"],"prefix":"10.1007","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6337-6636","authenticated-orcid":false,"given":"Robina","family":"Aerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis","family":"Rica\u00f1o-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariolina","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostinho","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ECMM Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection Working Group Contributors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Sprute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Monoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Giaccobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"issue":"8","key":"831_CR1","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Walsh TJ, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European confederation of medical mycology in cooperation with the international society for human and animal mycology and the American society for microbiology. Lancet Infect Dis. 2021;21(8):e246\u201357.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"831_CR2","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","volume":"3","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022;3(7):e543\u201352.","journal-title":"Lancet Microbe"},{"issue":"8","key":"831_CR3","doi-asserted-by":"publisher","first-page":"myad074","DOI":"10.1093\/mmy\/myad074","volume":"61","author":"AF Henao-Mart\u00ednez","year":"2023","unstructured":"Henao-Mart\u00ednez AF, Corbisiero MF, Salter I, Chastain DB, Thompson GR III. Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality. Med Mycol. 2023;61(8):myad074.","journal-title":"Med Mycol"},{"issue":"7","key":"831_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/myc.12628","volume":"60","author":"OA Cornely","year":"2017","unstructured":"Cornely OA, Lass-Fl\u00f6rl C, Lagrou K, Arsic-Arsenijevic V, Hoenigl M. Improving outcome of fungal diseases\u2014guiding experts and patients towards excellence. Mycoses. 2017;60(7):420\u20135.","journal-title":"Mycoses"},{"issue":"6","key":"831_CR5","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/JCM.00467-14","volume":"52","author":"M Hoenigl","year":"2014","unstructured":"Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52(6):2039\u201345.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"831_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"831_CR7","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S2666-5247(22)00261-0","volume":"4","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Hoenigl M, Gangneux J-P, et al. The current state of laboratory mycology and access to antifungal treatment in Europe: a European confederation of medical mycology survey. The Lancet Microbe. 2023;4(1):e47\u201356.","journal-title":"The Lancet Microbe"},{"issue":"4","key":"831_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","volume":"46","author":"S Eigl","year":"2015","unstructured":"Eigl S, Prattes J, Reinwald M, et al. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents. 2015;46(4):401\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"831_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cmi.2015.09.009","volume":"22","author":"J Springer","year":"2016","unstructured":"Springer J, Lackner M, Nachbaur D, et al. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. Clin Microbiol Infect. 2016;22(1):80\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"831_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40121-017-0183-9","volume":"7","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Peghin M, Vena A. Challenges and solution of invasive aspergillosis in non-neutropenic patients: a review. Infect Dis Ther. 2018;7(1):17\u201327.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"831_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/jof5040116","volume":"5","author":"JD Jenks","year":"2019","unstructured":"Jenks JD, Rawlings SA, Garcia-Vidal C, et al. Immune parameters for diagnosis and treatment monitoring in invasive mold infection. J Fungi (Basel). 2019;5(4):116.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"831_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1086\/377099","volume":"188","author":"RM Winn","year":"2003","unstructured":"Winn RM, Gil-Lamaignere C, Roilides E, et al. Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of aspergillus species. J Infect Dis. 2003;188(4):585\u201390.","journal-title":"J Infect Dis"},{"issue":"12","key":"831_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/myc.12679","volume":"60","author":"S Heldt","year":"2017","unstructured":"Heldt S, Eigl S, Prattes J, et al. Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis. Mycoses. 2017;60(12):818\u201325.","journal-title":"Mycoses"},{"issue":"4","key":"831_CR14","doi-asserted-by":"publisher","first-page":"e23149","DOI":"10.1002\/jcla.23149","volume":"34","author":"Q Wang","year":"2020","unstructured":"Wang Q, Yang M, Wang C, Cui J, Li X, Wang C. Diagnostic efficacy of serum cytokines and chemokines in fungal bloodstream infection in febrile patients. J Clin Lab Anal. 2020;34(4):e23149.","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"831_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/jof7090753","volume":"7","author":"P Thammasit","year":"2021","unstructured":"Thammasit P, Sripetchwandee J, Nosanchuk JD, Chattipakorn SC, Chattipakorn N, Youngchim S. Cytokine and chemokine responses in invasive aspergillosis following hematopoietic stem cell transplantation: past evidence for future therapy of aspergillosis. J Fungi. 2021;7(9):753.","journal-title":"J Fungi."},{"issue":"4","key":"831_CR16","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4):e95192.","journal-title":"PLoS ONE"},{"issue":"7","key":"831_CR17","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"831_CR18","doi-asserted-by":"crossref","unstructured":"Noguchi K, Gel Y, Brunner E, Konietschke F. nparLD: an R software package for the nonparametric analysis of longitudinal data in factorial experiments. Journal of Statistical Software [Internet]. 2012; 50(12). Available from: https:\/\/www.jstatsoft.org\/v50\/i12\/","DOI":"10.18637\/jss.v050.i12"},{"issue":"21","key":"831_CR19","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1016\/j.jmb.2019.03.027","volume":"431","author":"BY Tischler","year":"2019","unstructured":"Tischler BY, Hohl TM. Menacing mold: recent advances in Aspergillus pathogenesis and host defense. J Mol Biol. 2019;431(21):4229\u201346.","journal-title":"J Mol Biol"},{"key":"831_CR20","doi-asserted-by":"publisher","unstructured":"Gon\u00e7alves SM, Lagrou K, Rodrigues CS, et al. Evaluation of bronchoalveolar lavage fluid cytokines as biomarkers for invasive pulmonary aspergillosis in at-risk patients. Frontiers in Microbiology [Internet]. 2017 [cited 2023 Feb 3]; [8]. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2017.02362","DOI":"10.3389\/fmicb.2017.02362"},{"issue":"10","key":"831_CR21","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1002\/eji.200737409","volume":"37","author":"T Zelante","year":"2007","unstructured":"Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol. 2007;37(10):2695\u2013706.","journal-title":"Eur J Immunol"},{"issue":"2","key":"831_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00281-014-0467-z","volume":"37","author":"KL Becker","year":"2015","unstructured":"Becker KL, Ifrim DC, Quintin J, Netea MG, van de Veerdonk FL. Antifungal innate immunity: recognition and inflammatory networks. Semin Immunopathol. 2015;37(2):107\u201316.","journal-title":"Semin Immunopathol"},{"issue":"2","key":"831_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1073\/pnas.97.2.773","volume":"97","author":"H Li","year":"2000","unstructured":"Li H, Chen J, Huang A, et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci. 2000;97(2):773\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"831_CR24","doi-asserted-by":"publisher","unstructured":"Nies JF, Panzer U. IL-17C\/IL-17RE: emergence of a unique axis in TH17 biology. Frontiers in Immunology [Internet]. 2020 [cited 2023 Mar 7]; 11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2020.00341","DOI":"10.3389\/fimmu.2020.00341"},{"issue":"4","key":"831_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","volume":"35","author":"SH Chang","year":"2011","unstructured":"Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity. 2011;35(4):611\u201321.","journal-title":"Immunity"},{"key":"831_CR26","doi-asserted-by":"publisher","unstructured":"Brevi A, Cogrossi LL, Grazia G, et al. Much more than IL-17A: cytokines of the IL-17 family between microbiota and cancer. frontiers in immunology [Internet]. 2020 [cited 2023 Feb 7]; 11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2020.565470","DOI":"10.3389\/fimmu.2020.565470"},{"issue":"12","key":"831_CR27","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ni.2156","volume":"12","author":"V Ramirez-Carrozzi","year":"2011","unstructured":"Ramirez-Carrozzi V, Sambandam A, Luis E, et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol. 2011;12(12):1159\u201366.","journal-title":"Nat Immunol"},{"issue":"4","key":"831_CR28","doi-asserted-by":"publisher","first-page":"e0122807","DOI":"10.1371\/journal.pone.0122807","volume":"10","author":"HR Conti","year":"2015","unstructured":"Conti HR, Whibley N, Coleman BM, Garg AV, Jaycox JR, Gaffen SL. Signaling through IL-17C\/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS ONE. 2015;10(4):e0122807.","journal-title":"PLoS ONE"},{"issue":"4","key":"831_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/cmi.2015.56","volume":"13","author":"J Huang","year":"2016","unstructured":"Huang J, Meng S, Hong S, Lin X, Jin W, Dong C. IL-17C is required for lethal inflammation during systemic fungal infection. Cell Mol Immunol. 2016;13(4):474\u201383.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"831_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1165\/rcmb.2012-0232OC","volume":"48","author":"P Pfeifer","year":"2013","unstructured":"Pfeifer P, Voss M, Wonnenberg B, et al. IL-17C Is a mediator of respiratory epithelial innate immune response. Am J Respir Cell Mol Biol. 2013;48(4):415\u201321.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"831_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4049\/jimmunol.1800547","volume":"202","author":"KC Jamieson","year":"2019","unstructured":"Jamieson KC, Traves SL, Kooi C, et al. Rhinovirus and bacteria synergistically induce IL-17C release from human airway epithelial cells to promote neutrophil recruitment. J Immunol. 2019;202(1):160\u201370.","journal-title":"J Immunol"},{"issue":"12","key":"831_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ni.2155","volume":"12","author":"X Song","year":"2011","unstructured":"Song X, Zhu S, Shi P, et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol. 2011;12(12):1151\u20138.","journal-title":"Nat Immunol"},{"issue":"1","key":"831_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.immuni.2007.05.016","volume":"27","author":"MJ Butte","year":"2007","unstructured":"Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7\u20131 costimulatory molecule to inhibit T cell responses. Immunity. 2007;27(1):111\u201322.","journal-title":"Immunity"},{"issue":"12","key":"831_CR34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S1470-2045(17)30852-5","volume":"18","author":"N Daver","year":"2017","unstructured":"Daver N, Kontoyiannis DP. Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis. Lancet Oncol. 2017;18(12):1571\u20133.","journal-title":"Lancet Oncol"},{"issue":"1","key":"831_CR35","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1038\/s41467-022-34722-7","volume":"13","author":"Y Yu","year":"2022","unstructured":"Yu Y, Wang R-R, Miao N-J, et al. PD-L1 negatively regulates antifungal immunity by inhibiting neutrophil release from bone marrow. Nat Commun. 2022;13(1):6857.","journal-title":"Nat Commun"},{"issue":"2","key":"831_CR36","doi-asserted-by":"publisher","first-page":"e0081721","DOI":"10.1128\/msphere.00817-21","volume":"7","author":"S Wurster","year":"2022","unstructured":"Wurster S, Albert ND, Kontoyiannis DP. Candida auris bloodstream infection induces upregulation of the PD-1\/PD-L1 immune checkpoint pathway in an immunocompetent mouse model. Msphere. 2022;7(2):e0081721.","journal-title":"Msphere."},{"issue":"1","key":"831_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","volume":"17","author":"D Grimaldi","year":"2017","unstructured":"Grimaldi D, Pradier O, Hotchkiss RS, Vincent J-L. Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis. Lancet Infect Dis. 2017;17(1):18.","journal-title":"Lancet Infect Dis"},{"key":"831_CR38","doi-asserted-by":"publisher","first-page":"838344","DOI":"10.3389\/fimmu.2022.838344","volume":"13","author":"S Wurster","year":"2022","unstructured":"Wurster S, Albert ND, Bharadwaj U, et al. Blockade of the PD-1\/PD-L1 immune checkpoint pathway improves infection outcomes and enhances fungicidal host defense in a murine model of invasive pulmonary mucormycosis. Front Immunol. 2022;13:838344.","journal-title":"Front Immunol"},{"issue":"7","key":"831_CR39","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1073\/pnas.0711918105","volume":"105","author":"E L\u00e1z\u00e1r-Moln\u00e1r","year":"2008","unstructured":"L\u00e1z\u00e1r-Moln\u00e1r E, G\u00e1cser A, Freeman GJ, Almo SC, Nathenson SG, Nosanchuk JD. The PD-1\/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci U S A. 2008;105(7):2658\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"831_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fmicb.2015.00429","volume":"6","author":"R Thakur","year":"2015","unstructured":"Thakur R, Anand R, Tiwari S, Singh AP, Tiwary BN, Shankar J. Cytokines induce effector T-helper cells during invasive aspergillosis; What we have learned about T-helper cells? Front Microbiol. 2015;6:429.","journal-title":"Front Microbiol"},{"issue":"3","key":"831_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1389201003378924","volume":"1","author":"A Mencacci","year":"2000","unstructured":"Mencacci A, Cenci E, Bacci A, Montagnoli C, Bistoni F, Romani L. Cytokines in candidiasis and aspergillosis. Curr Pharm Biotechnol. 2000;1(3):235\u201351.","journal-title":"Curr Pharm Biotechnol"},{"issue":"7","key":"831_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/13693780500088333","volume":"43","author":"A Warris","year":"2005","unstructured":"Warris A, Netea MG, Verweij PE, et al. Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi. Med Mycol. 2005;43(7):613\u201321.","journal-title":"Med Mycol"},{"issue":"3","key":"831_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/cei.12725","volume":"183","author":"O Supasorn","year":"2016","unstructured":"Supasorn O, Sringkarin N, Srimanote P, Angkasekwinai P. Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection. Clin Exp Immunol. 2016;183(3):431\u201340.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"831_CR44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.survophthal.2023.06.007","volume":"68","author":"C Garc\u00eda-L\u00f3pez","year":"2023","unstructured":"Garc\u00eda-L\u00f3pez C, Rodr\u00edguez-Calvo-de-Mora M, Borroni D, S\u00e1nchez-Gonz\u00e1lez J-M, Romano V, Rocha-de-Lossada C. The role of matrix metalloproteinases in infectious corneal ulcers. Surv Ophthalmol. 2023;68(5):929\u201339.","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"831_CR45","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.micinf.2007.03.015","volume":"9","author":"V Gafa","year":"2007","unstructured":"Gafa V, Remoli ME, Giacomini E, et al. In vitro infection of human dendritic cells by aspergillus fumigatus conidia triggers the secretion of chemokines for neutrophil and Th1 lymphocyte recruitment. Microbes Infect. 2007;9(8):971\u201380.","journal-title":"Microbes Infect"},{"issue":"8","key":"831_CR46","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.4049\/jimmunol.0901027","volume":"183","author":"AJ Hartigan","year":"2009","unstructured":"Hartigan AJ, Westwick J, Jarai G, Hogaboam CM. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis1. J Immunol. 2009;183(8):5171\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"831_CR47","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.18632\/aging.203898","volume":"14","author":"J-R Blanco","year":"2022","unstructured":"Blanco J-R, Cobos-Ceballos M-J, Navarro F, et al. Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease. Aging (Albany NY). 2022;14(4):1597\u2013610.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"831_CR48","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/315027","volume":"180","author":"P Borger","year":"1999","unstructured":"Borger P, Ko\u00ebter GH, Timmerman JA, Vellenga E, Tomee JF, Kauffman HF. Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis. 1999;180(4):1267\u201374.","journal-title":"J Infect Dis"},{"issue":"2","key":"831_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/infdis\/jiv027","volume":"212","author":"S Bidula","year":"2015","unstructured":"Bidula S, Sexton DW, Abdolrasouli A, et al. The serum opsonin L-ficolin is detected in lungs of human transplant recipients following fungal infections and modulates inflammation and killing of aspergillus fumigatus. J Infect Dis. 2015;212(2):234\u201346.","journal-title":"J Infect Dis"},{"issue":"3","key":"831_CR50","first-page":"323","volume":"55","author":"MS Ghufran","year":"2017","unstructured":"Ghufran MS, Ghosh K, Kanade SR. A fucose specific lectin from Aspergillus flavus induced interleukin-8 expression is mediated by mitogen activated protein kinase p38. Med Mycol. 2017;55(3):323\u201333.","journal-title":"Med Mycol"},{"issue":"3","key":"831_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jinf.2018.05.001","volume":"77","author":"S Heldt","year":"2018","unstructured":"Heldt S, Prattes J, Eigl S, et al. Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect. 2018;77(3):235\u201341.","journal-title":"J Infect"},{"issue":"9","key":"831_CR52","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1086\/656527","volume":"202","author":"LA Chai","year":"2010","unstructured":"Chai LA, Netea MG, Teerenstra S, et al. Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive aspergillosis. J Infect Dis. 2010;202(9):1454\u201362.","journal-title":"J Infect Dis"},{"issue":"7","key":"831_CR53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cid\/cir441","volume":"53","author":"SA Nou\u00e9r","year":"2011","unstructured":"Nou\u00e9r SA, Nucci M, Kumar NS, Grazziutti M, Barlogie B, Anaissie E. Earlier response assessment in invasive aspergillosis based on the kinetics of serum aspergillus galactomannan: proposal for a new definition. Clin Infect Dis. 2011;53(7):671\u20136.","journal-title":"Clin Infect Dis"},{"key":"831_CR54","doi-asserted-by":"crossref","unstructured":"Geurts K, Zweijpfenning SMH, Pennings LJ, et al. Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde? European Respiratory Journal [Internet]. European Respiratory Society; 2019 [cited 2023 Dec 22]; 54(1). Available from: https:\/\/erj-ersjournals-com.kuleuven.e-bronnen.be\/content\/54\/1\/1900117","DOI":"10.1183\/13993003.00117-2019"},{"issue":"8","key":"831_CR55","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7(8):1127\u201340.","journal-title":"Nat Microbiol"},{"issue":"1","key":"831_CR56","doi-asserted-by":"publisher","first-page":"e760","DOI":"10.1002\/iid3.760","volume":"11","author":"H Ni","year":"2023","unstructured":"Ni H, Yu H, Lin Q, Zhong J, Sun W, Nie H. Analysis of risk factors of fungal superinfections in viral pneumonia patients: a systematic review and meta-analysis. Immun Inflamm Dis. 2023;11(1):e760.","journal-title":"Immun Inflamm Dis"},{"issue":"5","key":"831_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1211161","volume":"370","author":"C Cunha","year":"2014","unstructured":"Cunha C, Aversa F, Lacerda JF, et al. Genetic Ptx3 deficiency and aspergillosis in stem cell transplantation. New Engl J Med. 2014;370(5):421\u201332.","journal-title":"New Engl J Med."},{"issue":"19","key":"831_CR58","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2016-10-743294","volume":"129","author":"CE Fisher","year":"2017","unstructured":"Fisher CE, Hohl TM, Fan W, et al. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood. 2017;129(19):2693\u2013701.","journal-title":"Blood"},{"issue":"16","key":"831_CR59","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMra2027424","volume":"385","author":"GR Thompson","year":"2021","unstructured":"Thompson GR, Young J-AH. Aspergillus infections. New Engl J Med. 2021;385(16):1496\u2013509.","journal-title":"New Engl J Med."},{"issue":"1","key":"831_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.chom.2015.12.002","volume":"19","author":"T Akoumianaki","year":"2016","unstructured":"Akoumianaki T, Kyrmizi I, Valsecchi I, et al. Aspergillus cell wall melanin blocks LC3-associated phagocytosis to promote pathogenicity. Cell Host Microbe. 2016;19(1):79\u201390.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"831_CR61","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cid\/ciu337","volume":"59","author":"JF Camargo","year":"2014","unstructured":"Camargo JF, Husain S. Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis. 2014;59(4):569\u201377.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"831_CR62","doi-asserted-by":"publisher","first-page":"e1003436","DOI":"10.1371\/journal.ppat.1003436","volume":"9","author":"SM Leal","year":"2013","unstructured":"Leal SM, Roy S, Vareechon C, et al. Targeting iron acquisition blocks infection with the fungal pathogens aspergillus fumigatus and fusarium oxysporum. PLoS Pathog. 2013;9(7):e1003436.","journal-title":"PLoS Pathog"},{"issue":"13","key":"831_CR63","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","volume":"100","author":"H Hebart","year":"2002","unstructured":"Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002;100(13):4521\u20138.","journal-title":"Blood"},{"issue":"3","key":"831_CR64","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/QCO.0b013e32835fb920","volume":"26","author":"C Garcia-Vidal","year":"2013","unstructured":"Garcia-Vidal C, Viasus D, Carratal\u00e0 J. Pathogenesis of invasive fungal infections. Curr Opin Infect Dis. 2013;26(3):270\u20136.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"831_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jof3040055","volume":"3","author":"IMW Dewi","year":"2017","unstructured":"Dewi IMW, Van de Veerdonk FL, Gresnigt MS. The multifaceted role of T-helper responses in host defense against aspergillus fumigatus. J Fungi. 2017;3(4):55.","journal-title":"J Fungi."}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-024-00831-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T14:08:11Z","timestamp":1714226891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-024-00831-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s11046-024-00831-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3397911\/v1","asserted-by":"object"}]},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TM has received consultancy fees from Gilead Sciences, Pfizer and AstraZeneca, research grants from Gilead Sciences, and travel support from AstraZeneca. JM reports grants and personal fees from Bio-Rad, personal fees and non-financial support from Astellas and Basilea, and grants, personal fees and non-financial support from Gilead Sciences, Merck Sharp and Dohme, F2G, Mundipharma and Pfizer. MGN is a scientific founder of TTxD, Biotrip and Lemba. MH received research funding from Gilead, Astellas, MSD, Mundipharma, Pulmocide, Euroimmune, Scynexis, F2G and Pfizer. Other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"24"}}